Document is current
Any future updates will be listed below
-
Authors
Cowan, Kelly http://orcid.org/0000-0001-8204-5680
Semmens, Erin O.
Lee, Jeannette Y.
Walker, Ethan S.
Smith, Paul G.
Fu, Linda
Singleton, Rosalyn
Cox, Sara McClure
Faiella, Jennifer
Chassereau, Laurie
Lawrence, Lora
Ying, Jun
Baldner, Jaime
Garza, Maryam
Annett, Robert
Chervinskiy, Sheva K.
Snowden, Jessica
-
Funding
Funding for this research was provided by:
NIH (U24 OD024957, UG1 OD024942, UG1 OD024943, UG1 OD024944, UG1 OD024945, UG1 OD024946, UG1 OD024947, UG1 OD024948, UG1 OD030016, UG1 OD024950, UG1 OD024951, UG1 OD024952, UG1 OD024953, UG1 OD024954, UG1 OD024955, UG1 OD024956, UG1 OD024959, UG1 OD030019)
NIGMS (P20GM130418)
- License Information
-
More Information
Article History
Received: 4 December 2023
Accepted: 23 February 2024
First Online: 20 March 2024
Declarations
:
: The University of Arkansas for Medical Sciences Institutional Review Board (FWA0000119) and Alaska Area IRB approved this protocol. Written, informed consent to participate will be obtained from the legal guardians of all participants<i>.</i> Please refer to separately submitted documents.
: Not applicable.
: Jessica Snowden, MD, discloses a relevant financial relationship with the ineligible company Pfizer. Dr. Snowden is a consultant for the Pfizer company; however, all potential conflicts of interest have been mitigated. The other authors have no competing interests.
